Prevention
It is globally acknowledged that prevention is better than cure and yet most health systems spend less than 1% of their budgets on preventative approaches. A preventative approach can help reduce healthcare costs, improve patient outcomes, and decrease the burden on healthcare systems.

OHE’s submission for the DHSC’s next 10 years of planning
9 December 2024
This Insight summarises the recommendations OHE submitted towards the Department of Health & Social Care’s consultation on the next 10 years of planning for the NHS.

The Preventive Health Revolution: Insights from the 2024 Annual Lecture
15 October 2024
One of OHE’s charitable objectives is a commitment to educate and inform the public and policymakers about critical issues in the healthcare sector. OHE’s Annual Lecture…

Green Healthcare: Are We Asking the Right Questions?
11 September 2024
The climate-health crisis is a growing global concern, and identifying the right starting points is crucial.

OHE Annual Lecture 2024 | The Preventive Health Revolution: Live Longer, Live Better
10 September 2024
In this lecture, Professor Andrew Scott re-evaluated prominent perceptions of ageing and argued for the need to focus on a longevity society and explore the key…

Socio-Economic Value of Adult Immunisation Programmes
18 April 2024
Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised.

The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target?
24 January 2024
Cervical cancer imposes a substantial burden on patients, their support networks, the NHS, and society at large. This report underscores the significant socioeconomic savings that can be achieved by reaching the WHO’s elimination goal of 4 cases per 100,000 women, providing further impetus to take action to reach the ambitious 2040 elimination target set by NHS England.

Individual, Health System, and Societal Impacts of Anti-seizure Medicine Use During Pregnancy
23 January 2024
Explore the implications of in utero exposure to anti-seizure medications (ASMs), the heightened risks of developmental problems and physical disabilities. The economic impact associated with conditions like epilepsy, stressing the urgent need for detailed risk profiles and data collection to guide interventions and reduce the societal costs linked to ASM use during pregnancy.

Could Plant-based Diets Transform Health Care Spending?
8 January 2024
In a bid to reduce health care budgets, policymakers and healthcare professionals are increasingly looking to prevention strategies.

A switch to vegan diets could save the NHS £6.7 billion per year, new research reveals
8 January 2024
A new study by the Office of Health Economics shows that with 100% adoption of plant-based diets in England, the total health care cost savings for…